Phathom Pharmaceuticals, Inc. (PHAT)
5.74
-0.48
(-7.72%)
USD |
NASDAQ |
Oct 30, 16:00
5.85
+0.11
(+1.92%)
After-Hours: 20:00
Phathom Pharmaceuticals Market Cap : 459.60M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 459.60M |
| October 29, 2026 | 498.04M |
| October 28, 2026 | 502.84M |
| October 27, 2026 | 479.62M |
| October 26, 2026 | 475.62M |
| October 23, 2026 | 459.60M |
| October 22, 2026 | 561.29M |
| October 21, 2026 | 562.89M |
| October 20, 2026 | 585.31M |
| October 19, 2026 | 561.29M |
| October 16, 2026 | 554.08M |
| October 15, 2026 | 600.52M |
| October 14, 2026 | 592.52M |
| October 13, 2026 | 560.49M |
| October 12, 2026 | 570.90M |
| October 09, 2026 | 580.51M |
| October 08, 2026 | 570.90M |
| October 07, 2026 | 545.28M |
| October 06, 2026 | 542.87M |
| October 05, 2026 | 536.47M |
| October 02, 2026 | 554.08M |
| October 01, 2026 | 566.90M |
| September 30, 2026 | 584.51M |
| September 29, 2026 | 589.32M |
| September 28, 2026 | 588.51M |
| Date | Value |
|---|---|
| September 25, 2026 | 584.51M |
| September 24, 2026 | 566.90M |
| September 23, 2026 | 559.29M |
| September 22, 2026 | 621.34M |
| September 21, 2026 | 596.52M |
| September 18, 2026 | 598.92M |
| September 17, 2026 | 620.54M |
| September 16, 2026 | 615.74M |
| September 15, 2026 | 653.37M |
| September 14, 2026 | 695.01M |
| September 11, 2026 | 669.39M |
| September 10, 2026 | 670.19M |
| September 09, 2026 | 694.21M |
| September 08, 2026 | 755.06M |
| September 04, 2026 | 760.66M |
| September 03, 2026 | 724.63M |
| September 02, 2026 | 741.45M |
| September 01, 2026 | 751.86M |
| August 31, 2026 | 766.27M |
| August 28, 2026 | 735.04M |
| August 27, 2026 | 715.83M |
| August 26, 2026 | 702.21M |
| August 25, 2026 | 704.62M |
| August 24, 2026 | 693.41M |
| August 21, 2026 | 710.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.654B |
| Corcept Therapeutics, Inc. | 8.755B |
| Veru, Inc. | 37.34M |
| Johnson & Johnson | 657.62B |
| Eli Lilly & Co. | 1.334T |
Market Cap Related Metrics
| PS Ratio | 1.694 |
| Price | 5.74 |
| Earnings Yield | -17.95% |